Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5,166 out of 355,674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 137,911 | 157,200 |
| Total Cites | 21,959 | 23,700 |
| H-index | 63 | 64 |
| Hm-index | 16 | 16 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 2,815 | 2,937 |
| Number of Single+First+Last Authored Papers | 76 | 76 |
| Total Cites to Single+First+Last Authored Papers | 5,612 | 5,889 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 19,396 | 20,583 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
7.35%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5,443 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 144,819 | 160,985 |
| Total Cites | 18,792 | 20,319 |
| H-index | 56 | 59 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 2,714 | 2,832 |
| Number of Single+First+Last Authored Papers | 70 | 70 |
| Total Cites to Single+First+Last Authored Papers | 5,006 | 5,262 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 16,577 | 17,621 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.15 |
| Self-Citation Percentage |
7.52%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5,708 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 150,217 | 164,173 |
| Total Cites | 15,912 | 17,279 |
| H-index | 52 | 55 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 2,598 | 2,711 |
| Number of Single+First+Last Authored Papers | 66 | 66 |
| Total Cites to Single+First+Last Authored Papers | 4,427 | 4,663 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 14,012 | 14,949 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
7.91%
|
|
Fong, Lawrence
UCSF Helen Diller Family Comprehensive Cancer Center,
United States
2022 Rank: 154,018
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5,816 out of 293,195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 154,018 | 172,254 |
| Total Cites | 12,689 | 13,835 |
| H-index | 49 | 50 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 16 | 16 |
| Total Cites to Single+First Authored Papers | 2,455 | 2,564 |
| Number of Single+First+Last Authored Papers | 62 | 62 |
| Total Cites to Single+First+Last Authored Papers | 3,868 | 4,086 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 11,143 | 11,925 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.16 |
| Self-Citation Percentage |
8.28%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.